Schisandrin B ameliorates adjuvant-induced arthritis in rats via modulation of inflammatory mediators, oxidative stress, and HIF-1α/VEGF pathway
Journal of Pharmacy and Pharmacology · 01.06.2024 · 76 (6) · 681-690
DOI: 10.1093/jpp/rgae020 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, online erschienen am 01.06.2024. Verfasst von Xueqiang Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Huzhou Traditional Chinese Medicine Hospital Affiliated to Zhejiang Chinese Medical University, Huzhou 31300, Zhejiang, China. Hauptthemen laut MEDLINE: Cyclooctanes, Lignans, Oxidative Stress, Hypoxia-Inducible Factor 1, alpha Subunit. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objectives
Schisandrin B (Sch B) has been shown to possess anti-inflammatory and antioxidant properties, however, its antirheumatoid arthritis properties and potential mechanism remain unexplored. This study evaluated the potential of Sch B in adjuvant-induced arthritic (AIA) rats.
Methods
AIA was induced by injecting 0.1 ml of CFA into the paw of rats and the animals were administered with Sch B (50 mg/kg) for 28 days. The effects of Sch B were evaluated using arthritis severity, serum levels of oxido-inflammatory, and metabolic index parameters. Key findings Sch B eased arthritic symptoms by significantly reducing paw swelling and arthritic score and increased body weight gain. Moreover, Sch B alleviated the levels of oxido-inflammatory markers including interleukin-1 beta, interleukin-6, tumor necrosis factor alpha, nuclear factor kappa B, transforming growth factor β1, inducible nitric oxide synthase and malonaldehyde, as well as increased the levels of superoxide dismutase, glutathione, and Nrf2. Sch B also remarkably restored the altered levels of triglyceride, aspartate aminotransferase, lactic acid, pyruvate, phosphoenolpyruvate carboxylase, glucose, hypoxia inducible factor-1 alpha, and vascular endothelial growth factor. In addition, Sch B markedly alleviated p65 expression in the treated AIA rats.
Conclusion
This study suggests that Sch B alleviated AIA by reducing oxidative stress, inflammation, and angiogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Huzhou Traditional Chinese Medicine Hospital Affiliated to Zhejiang Chinese Medical University, Huzhou 31300, Zhejiang, China.
- The Second Peoples Hospital of Wuhu City, Wuhu 241000, China.
- Research Center of Integration of Traditional Chinese and Western Medicine, Wannan Medical College, Wuhu 241000, China.
- African Genome Center, University Mohammed VI Polytechnic, Ben Guerir 43150, Morocco.
ORCID-Profile: Opeyemi Joshua Olatunji
Zitieren
APA
Chen, X., Liu, C., Deng, J., Xia, T., Zhang, X., Xue, S., Song, M. K., & Olatunji, O. J. (2024). Schisandrin B ameliorates adjuvant-induced arthritis in rats via modulation of inflammatory mediators, oxidative stress, and HIF-1α/VEGF pathway. Journal of Pharmacy and Pharmacology, 76(6), 681-690. https://doi.org/10.1093/jpp/rgae020
Vancouver
Chen X, Liu C, Deng J, Xia T, Zhang X, Xue S, et al. Schisandrin B ameliorates adjuvant-induced arthritis in rats via modulation of inflammatory mediators, oxidative stress, and HIF-1α/VEGF pathway. Journal of Pharmacy and Pharmacology. 2024;76(6):681-690. doi:10.1093/jpp/rgae020
BibTeX
@article{Chen2024,
author = {Chen, Xueqiang and Liu, Chunhong and Deng, Jiaxin and Xia, Taibao and Zhang, Xiaohai and Xue, Shuangtao and Song, Meng-Ke and Olatunji, Opeyemi Joshua},
title = {Schisandrin B ameliorates adjuvant-induced arthritis in rats via modulation of inflammatory mediators, oxidative stress, and HIF-1α/VEGF pathway},
journal = {Journal of Pharmacy and Pharmacology},
year = {2024},
volume = {76},
number = {6},
pages = {681--690},
doi = {10.1093/jpp/rgae020}
}
EUVIMED